Literature DB >> 20399342

The significance of anabolic androgenic steroids in a Swedish prison population.

Fia Klötz1, Anna Petersson, Orsolya Hoffman, Ingemar Thiblin.   

Abstract

Use of anabolic androgenic steroids (AAS) has been associated with adverse psychiatric effect, violent behavior, and criminality. The aim of this study was to further investigate the motives for and consequences of AAS use, with focus on violent and antisocial behavior. Fifty-nine prisoners were interviewed on their use of AAS, and their history was mapped with Addiction Severity Index interviews. Of these prisoners, 56% admitted previous use of AAS, of whom 24% declared to have committed violent crimes in connection with use of AAS. However, the only significant difference between users and nonusers with regard to criminal history when measured with the Addiction Severity Index was that the AAS users more often stated that they had been prosecuted for crimes labeled as "other crimes," which did not include violent crimes. The reported side effects of AAS corresponded well to those previously reported. These results indicate that use of AAS is common among Swedish prisoners and that the motives and consequences of such use are similar to what has been observed in other AAS-using populations. Furthermore, this study supports earlier notions that misuse of AAS might cause violent behavior, but only in certain individuals and mainly in combination with other substances. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20399342     DOI: 10.1016/j.comppsych.2009.05.007

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  8 in total

Review 1.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

Review 2.  Illicit use of androgens and other hormones: recent advances.

Authors:  Gen Kanayama; Harrison G Pope
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-06       Impact factor: 3.243

3.  ADHD symptoms and use of anabolic androgenic steroids among male weightlifters.

Authors:  Emilie Kildal; Bjørnar Hassel; Astrid Bjørnebekk
Journal:  Sci Rep       Date:  2022-06-08       Impact factor: 4.996

Review 4.  The aetiology and trajectory of anabolic-androgenic steroid use initiation: a systematic review and synthesis of qualitative research.

Authors:  Dominic Sagoe; Cecilie Schou Andreassen; Ståle Pallesen
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-07-02

Review 5.  Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis.

Authors:  Dominic Sagoe; Jim McVeigh; Astrid Bjørnebekk; Marie-Stella Essilfie; Cecilie Schou Andreassen; Ståle Pallesen
Journal:  Subst Abuse Treat Prev Policy       Date:  2015-03-15

6.  Effects of different doses of testosterone on gonadotropins, 25-hydroxyvitamin D3, and blood lipids in healthy men.

Authors:  Nina Gårevik; Anders Rane; Linda Björkhem-Bergman; Lena Ekström
Journal:  Subst Abuse Rehabil       Date:  2014-12-10

7.  Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires.

Authors:  Ingrid Amalia Havnes; Marie Lindvik Jørstad; Christine Wisløff
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-05-16

Review 8.  Toxicological Characterization of GHB as a Performance-Enhancing Drug.

Authors:  Arianna Giorgetti; Francesco Paolo Busardò; Raffaele Giorgetti
Journal:  Front Psychiatry       Date:  2022-04-18       Impact factor: 5.435

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.